CASTELLI, MATTEO
 Distribuzione geografica
Continente #
EU - Europa 917
NA - Nord America 805
AS - Asia 692
SA - Sud America 196
AF - Africa 19
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 2.631
Nazione #
US - Stati Uniti d'America 767
RU - Federazione Russa 519
CN - Cina 237
SG - Singapore 212
BR - Brasile 160
SE - Svezia 116
IT - Italia 95
VN - Vietnam 90
HK - Hong Kong 84
DE - Germania 54
FR - Francia 41
FI - Finlandia 26
CA - Canada 24
GB - Regno Unito 20
PL - Polonia 18
IN - India 14
AR - Argentina 13
MX - Messico 12
JP - Giappone 11
ZA - Sudafrica 10
EC - Ecuador 9
BD - Bangladesh 7
NL - Olanda 7
ES - Italia 6
CO - Colombia 5
TR - Turchia 5
CL - Cile 4
IE - Irlanda 4
IQ - Iraq 4
JO - Giordania 4
PH - Filippine 4
UZ - Uzbekistan 4
ID - Indonesia 3
PK - Pakistan 3
UA - Ucraina 3
AE - Emirati Arabi Uniti 2
EG - Egitto 2
MY - Malesia 2
PY - Paraguay 2
RO - Romania 2
AF - Afghanistan, Repubblica islamica di 1
AT - Austria 1
AU - Australia 1
BE - Belgio 1
BG - Bulgaria 1
CR - Costa Rica 1
DK - Danimarca 1
DZ - Algeria 1
EU - Europa 1
GA - Gabon 1
HR - Croazia 1
JM - Giamaica 1
KE - Kenya 1
KR - Corea 1
KZ - Kazakistan 1
LT - Lituania 1
MA - Marocco 1
MU - Mauritius 1
PE - Perù 1
PS - Palestinian Territory 1
SN - Senegal 1
TH - Thailandia 1
TN - Tunisia 1
TW - Taiwan 1
UY - Uruguay 1
VE - Venezuela 1
Totale 2.631
Città #
Dallas 235
Ashburn 135
Moscow 109
Singapore 105
Hong Kong 84
Milan 54
Shanghai 51
San Jose 47
Beijing 44
Ho Chi Minh City 37
Hefei 30
New York 28
Lauterbourg 26
Los Angeles 26
Princeton 24
Lawrence 23
Helsinki 19
São Paulo 19
Munich 17
Hanoi 16
Warsaw 15
Brescia 10
Tokyo 10
Chennai 9
Falkenstein 9
Stockholm 9
Orem 8
Atlanta 7
Frankfurt am Main 7
Amsterdam 6
Cesano Boscone 6
Denver 6
Johannesburg 6
London 6
Montreal 6
Nuremberg 6
Boston 5
Brooklyn 5
Chicago 5
Poplar 5
Rome 5
Toronto 5
Bologna 4
Columbus 4
Dublin 4
Guangzhou 4
Haiphong 4
San Francisco 4
Santa Clara 4
Seattle 4
The Dalles 4
Vancouver 4
Amman 3
Da Nang 3
Frankfurt Am Main 3
Guayaquil 3
Joinville 3
Lappeenranta 3
Manaus 3
Mexico City 3
Passo Fundo 3
Phoenix 3
Quito 3
Salvador 3
Tashkent 3
Turku 3
Xi'an 3
Ancona 2
Ankara 2
Bandung 2
Barra Mansa 2
Betim 2
Boardman 2
Bogotá 2
Brasília 2
Calgary 2
Cape Town 2
City of London 2
Como 2
Council Bluffs 2
Curitiba 2
Erbil 2
Ferraz de Vasconcelos 2
Florianópolis 2
Guarulhos 2
Houston 2
Jiaxing 2
Kassel 2
Manila 2
Muriaé 2
New Delhi 2
Ninh Bình 2
Niterói 2
Pune 2
Querétaro 2
Santo André 2
Secaucus 2
São José 2
São José dos Campos 2
Washington 2
Totale 1.436
Nome #
Evaluation of respiratory virus transmissibility and resilience from fomites: the case of 11 SARS-CoV-2 clinical isolates 177
Interferon-β 1a inhibits SARS-CoV-2 in vitro when administered after virus infection 127
A Biologically-validated HCV E1E2 Heterodimer Structural Model 125
Nanopore ReCappable sequencing maps SARS-CoV-2 5' capping sites and provides new insights into the structure of sgRNAs 121
A Human Stem Cell-Derived Neurosensory–Epithelial Circuitry on a Chip to Model Herpes Simplex Virus Reactivation 120
Cell-to-cell spread-blocking activity is extremely limited in the sera of HSV-1 and HSV-2 infected subjects 119
Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro 115
Mechanisms of Hepatitis C Virus Escape from Vaccine-Relevant Neutralizing Antibodies 106
Broadly neutralizing anti-influenza human monoclonal antibodies and their possible role in predictive medicine 96
IN VIVO PROTECTION CONFERRED BY HUMAN MONOCLONAL ANTIBODY DIRECTED AGAINST HSV-1 AND 2 96
Single spike mutation differentiating XBB.1 and XBB.1.5 enhances SARS-CoV-2 cell-to-cell transmission and facilitates serum-mediated enhancement 95
Neutralization Interfering Antibodies: a "Novel" Mechanism of Humoral Immune Mutiny and Viral Evasion? 91
Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols 91
Destructive extraction of phospholipids from Escherichia coli membranes by graphene nanosheets 90
Broad-range neutralizing anti-influenza A human monoclonal antibodies: new perspectives in therapy and prophylaxis. 86
Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein 86
Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines 80
Global and local envelope protein dynamics of hepatitis C virus determine broad antibody sensitivity 79
Characterization of a lineage c.36 sars-cov-2 isolate with reduced susceptibility to neutralization circulating in lombardy, italy 79
Characterization of epitopes recognized by monoclonal antibodies: experimental approaches supported by freely accessible bioinformatic tools 78
Peptide-based vaccinology: experimental and computational approaches to target hypervariable viruses through the fine characterization of protective epitopes recognized by monoclonal antibodies and the identification of T-cell-activating peptides. 77
HCV E2 core structures and mAbs: something is still missing 71
Role and potential therapeutic use of antibodies against herpetic infections 69
Unveiling the role of PUS7-mediated pseudouridylation in host protein interactions specific for the SARS-CoV-2 RNA genome 68
Viral Respiratory Pathogens and Lung Injury 68
Phage display-based strategies for cloning and optimization of monoclonal antibodies directed against human pathogens 60
Erratum: Destructive extraction of phospholipids from Escherichia coli membranes by graphene nanosheets (Nature Nanotechnology (2013) 8 (594-601)) 59
Sites of vulnerability in HCV E1E2 identified by comprehensive functional screening 57
Synergy evaluation of anti-Herpes Simplex Virus type 1 and 2 compounds acting on different steps of virus life cycle 57
Salts drive controllable multilayered upright assembly of amyloid-like peptides at mica/water interface 56
null 1
Totale 2.700
Categoria #
all - tutte 13.324
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.324


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215 0 0 0 0 0 0 0 0 0 5 0 0
2021/202230 2 1 7 4 0 0 0 2 2 3 3 6
2022/2023186 57 45 25 1 1 27 10 11 7 0 2 0
2023/2024161 0 9 26 30 14 33 4 20 4 9 1 11
2024/2025451 45 11 6 19 20 51 82 79 49 28 32 29
2025/20261.824 153 171 271 254 164 56 122 135 445 53 0 0
Totale 2.700